Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

A Co-localized Hepatitis C Virus Clinic in a Primary Care Practice Improves Linkage to Care in a High Prevalence Population.

Adamson PC, Miceli J, Shiferaw B, Villaneuva MS, Canterino JE.

Am J Med. 2020 Jan 24. pii: S0002-9343(20)30039-5. doi: 10.1016/j.amjmed.2019.12.028. [Epub ahead of print]

PMID:
31987799
2.

Prevalence and risk factors for HIV-1 infection in people who use illicit drugs in northern Brazil.

Oliveira-Filho AB, Silva FQ, Santos FJA, Cardoso YMN, Di Miceli JFF, Resque RL, Silva-Oliveira GC, Martins LC, Pinheiro LML, Machado LFA, Pinto AR, Lemos JAR, Fischer B, Kupek E.

Trans R Soc Trop Med Hyg. 2019 Nov 20. pii: trz106. doi: 10.1093/trstmh/trz106. [Epub ahead of print]

PMID:
31746322
3.

A case series of profound bradycardia in patients with severe anorexia nervosa: Thou shall not pace?

Cotter R, Lyden J, Mehler PS, Miceli J, Schuller J, Krantz MJ.

HeartRhythm Case Rep. 2019 Aug 5;5(10):511-515. doi: 10.1016/j.hrcr.2019.07.011. eCollection 2019 Oct. No abstract available.

4.

Implementing a Comprehensive HCV Clinic within an HIV Clinic: A Model of Care for HCV Micro-elimination.

Rizk C, Miceli J, Shiferaw B, Malinis M, Barakat L, Ogbuagu O, Villanueva M.

Open Forum Infect Dis. 2019 Aug 14. pii: ofz361. doi: 10.1093/ofid/ofz361. [Epub ahead of print]

5.

Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region.

Oliveira-Filho AB, Santos FJA, Silva FQ, Raiol NC, Costa CCS, Piauiense JNF, Martins LC, Cardoso YMN, Di Miceli JFF, Resque RL, Silva-Oliveira GC, Pinheiro LML, Machado LFA, Pinho JRR, Lemos JAR, Kupek E, Fischer B.

BMC Infect Dis. 2019 Jul 17;19(1):634. doi: 10.1186/s12879-019-4270-2.

6.

Psychosocial and behavioral pathways of metabolic syndrome in cancer caregivers.

Steel JL, Cheng H, Pathak R, Wang Y, Miceli J, Hecht CL, Haggerty D, Peddada S, Geller DA, Marsh W, Antoni M, Jones R, Kamarck T, Tsung A.

Psychooncology. 2019 Aug;28(8):1735-1742. doi: 10.1002/pon.5147. Epub 2019 Jul 8.

PMID:
31206896
7.

Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.

Geraldino-Pardilla L, Perel-Winkler A, Miceli J, Neville K, Danias G, Nguyen S, Dervieux T, Kapoor T, Giles J, Askanase A.

Lupus. 2019 Jun;28(7):862-867. doi: 10.1177/0961203319851558. Epub 2019 May 24.

PMID:
31122136
8.

Illness perceptions and perceived stress in patients with advanced gastrointestinal cancer.

Miceli J, Geller D, Tsung A, Hecht CL, Wang Y, Pathak R, Cheng H, Marsh W, Antoni M, Penedo F, Burke L, Ell K, Shen S, Steel J.

Psychooncology. 2019 Jul;28(7):1513-1519. doi: 10.1002/pon.5108. Epub 2019 Jun 4.

PMID:
31090125
10.

What's in a sample? Increasing transparency in biospecimen procurement methods.

LaBaer J, Miceli JF 3rd, Freedman LP.

Nat Methods. 2018 Apr 27;15(5):303-304. doi: 10.1038/nmeth.4684. No abstract available.

PMID:
29702632
11.

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil.

Fullerton T, Binneman B, David W, Delnomdedieu M, Kupiec J, Lockwood P, Mancuso J, Miceli J, Bell J.

Alzheimers Res Ther. 2018 Apr 5;10(1):38. doi: 10.1186/s13195-018-0368-9.

12.

Impact of carbon monoxide partial pressures on methanogenesis and medium chain fatty acids production during ethanol fermentation.

Esquivel-Elizondo S, Miceli J 3rd, Torres CI, Krajmalnik-Brown R.

Biotechnol Bioeng. 2018 Feb;115(2):341-350. doi: 10.1002/bit.26471. Epub 2017 Oct 30.

PMID:
28987001
13.

Determining the Mechanism for Low Sludge Yields in the Cannibal Solids Reduction System.

Van Ginkel SW, Miceli J, Kim BO, Yang Z, Young M, Marcus A, Rittmann BE.

Water Environ Res. 2018 Jan 1;90(1):42-47. doi: 10.2175/106143017X14839994523947. Epub 2017 Mar 16.

PMID:
28327257
14.

Shifting the balance of fermentation products between hydrogen and volatile fatty acids: microbial community structure and function.

Miceli JF 3rd, Torres CI, Krajmalnik-Brown R.

FEMS Microbiol Ecol. 2016 Dec;92(12). pii: fiw195. Epub 2016 Sep 14.

15.

Combining microbial cultures for efficient production of electricity from butyrate in a microbial electrochemical cell.

Miceli JF 3rd, Garcia-Peña I, Parameswaran P, Torres CI, Krajmalnik-Brown R.

Bioresour Technol. 2014 Oct;169:169-174. doi: 10.1016/j.biortech.2014.06.090. Epub 2014 Jul 2.

16.

Selective enrichment yields robust ethene-producing dechlorinating cultures from microcosms stalled at cis-dichloroethene.

Delgado AG, Kang DW, Nelson KG, Fajardo-Williams D, Miceli JF 3rd, Done HY, Popat SC, Krajmalnik-Brown R.

PLoS One. 2014 Jun 20;9(6):e100654. doi: 10.1371/journal.pone.0100654. eCollection 2014.

17.

Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.

Garcia-Borreguero D, Patrick J, DuBrava S, Becker PM, Lankford A, Chen C, Miceli J, Knapp L, Allen RP.

Sleep. 2014 Apr 1;37(4):635-43. doi: 10.5665/sleep.3558.

18.

Comparison of pregabalin with pramipexole for restless legs syndrome.

Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW.

N Engl J Med. 2014 Feb 13;370(7):621-31. doi: 10.1056/NEJMoa1303646.

19.

Enrichment and analysis of anode-respiring bacteria from diverse anaerobic inocula.

Miceli JF 3rd, Parameswaran P, Kang DW, Krajmalnik-Brown R, Torres CI.

Environ Sci Technol. 2012 Sep 18;46(18):10349-55. doi: 10.1021/es301902h. Epub 2012 Aug 27.

PMID:
22909141
20.

Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.

Camm AJ, Karayal ON, Meltzer H, Kolluri S, O'Gorman C, Miceli J, Tensfeldt T, Kane JM.

CNS Drugs. 2012 Apr 1;26(4):351-65. doi: 10.2165/11599010-000000000-00000.

PMID:
22452529
21.

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.

Rickels K, Shiovitz TM, Ramey TS, Weaver JJ, Knapp LE, Miceli JJ.

Int Clin Psychopharmacol. 2012 May;27(3):142-50. doi: 10.1097/YIC.0b013e328350b133.

PMID:
22302014
22.

A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.

Allen R, Chen C, Soaita A, Wohlberg C, Knapp L, Peterson BT, García-Borreguero D, Miceli J.

Sleep Med. 2010 Jun;11(6):512-9. doi: 10.1016/j.sleep.2010.03.003. Epub 2010 May 13.

PMID:
20466589
23.

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.

Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano RJ, O'Gorman C, Harrigan RH.

Clin Ther. 2010 Mar;32(3):472-91. doi: 10.1016/j.clinthera.2010.03.003.

PMID:
20399985
24.

Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.

Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano R, O'Gorman C, Harrigan RH.

Pharmacotherapy. 2010 Feb;30(2):127-35. doi: 10.1592/phco.30.2.127.

PMID:
20099987
25.

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.

Vieta E, Ramey T, Keller D, English PA, Loebel AD, Miceli J.

J Psychopharmacol. 2010 Apr;24(4):547-58. doi: 10.1177/0269881108099418. Epub 2008 Dec 12.

PMID:
19074536
26.

Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.

DelBello MP, Versavel M, Ice K, Keller D, Miceli J.

J Child Adolesc Psychopharmacol. 2008 Oct;18(5):491-9. doi: 10.1089/cap.2008.008.

PMID:
18928413
27.

The effect of food on the absorption of oral ziprasidone.

Miceli JJ, Glue P, Alderman J, Wilner K.

Psychopharmacol Bull. 2007;40(3):58-68.

PMID:
18007569
28.

Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.

Sallee FR, Miceli JJ, Tensfeldt T, Robarge L, Wilner K, Patel NC.

J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):720-728. doi: 10.1097/01.chi.0000215347.93902.3e.

PMID:
16721322
29.

Electrocardiographic changes with ziprasidone.

Loebel A, Miceli J, Chappell P, Siu C.

J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):636-637. doi: 10.1097/01.chi.0000215151.53776.5a. No abstract available.

PMID:
16721311
30.

Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.

Miceli JJ, Wilner KD, Swan SK, Tensfeldt TG.

J Clin Pharmacol. 2005 Jun;45(6):620-30.

PMID:
15901743
31.

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.

Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M.

J Clin Psychopharmacol. 2004 Feb;24(1):62-9.

PMID:
14709949
32.

Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission.

Sallee FR, Gilbert DL, Vinks AA, Miceli JJ, Robarge L, Wilner K.

J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):902-7.

PMID:
12874491
33.

Ziprasidone metabolism, aldehyde oxidase, and clinical implications.

Beedham C, Miceli JJ, Obach RS.

J Clin Psychopharmacol. 2003 Jun;23(3):229-32. Review.

PMID:
12826984
34.

The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery.

Wilner KD, Anziano RJ, Johnson AC, Miceli JJ, Fricke JR, Titus CK.

J Clin Psychopharmacol. 2002 Apr;22(2):206-10.

PMID:
11910268
35.

Simple versus double jejunal pouch for reconstruction after total gastrectomy.

Gioffre' Florio MA, Bartolotta M, Miceli JC, Giacobbe G, Saitta FP, Paparo MT, Micali B.

Am J Surg. 2000 Jul;180(1):24-8.

PMID:
11036134
36.

The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.

Miceli JJ, Smith M, Robarge L, Morse T, Laurent A.

Br J Clin Pharmacol. 2000;49 Suppl 1:71S-76S.

37.

The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.

Miceli JJ, Anziano RJ, Robarge L, Hansen RA, Laurent A.

Br J Clin Pharmacol. 2000;49 Suppl 1:65S-70S.

39.

Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.

Miceli JJ, Wilner KD, Hansen RA, Johnson AC, Apseloff G, Gerber N.

Br J Clin Pharmacol. 2000;49 Suppl 1:5S-13S.

40.

[Vascular clamping in cirrhotic liver surgery].

Bartolotta M, Gioffrè Florio M, Manganaro T, Miceli J, Saitta FP, Micali B.

Chir Ital. 1999 Mar-Apr;51(2):145-9. Italian.

PMID:
10514930
41.

Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.

Prakash C, Cui D, Baxter JG, Bright GM, Miceli J, Wilner K.

Drug Metab Dispos. 1998 May;26(5):448-56.

PMID:
9571226
42.

The effect of timing of a standard meal on the pharmacokinetics and pharmacodynamics of the novel atypical antipsychotic agent ziprasidone.

Hamelin BA, Allard S, Laplante L, Miceli J, Wilner KD, Tremblay J, LeBel M.

Pharmacotherapy. 1998 Jan-Feb;18(1):9-15.

PMID:
9469675
43.

Bioavailability studies of drugs with nonlinear pharmacokinetics: II. Absolute bioavailability of intravenous phenytoin prodrug at therapeutic phenytoin serum concentrations determined by double-stable isotope technique.

Browne TR, Szabo GK, McEntegart C, Evans JE, Evans BA, Miceli JJ, Quon C, Dougherty CL, Kres J, Davoudi H.

J Clin Pharmacol. 1993 Jan;33(1):89-94.

PMID:
8429121
44.

Durnin, Miceli, and Eberly reply.

Durnin J, Miceli JJ Jr, Eberly JH.

Phys Rev Lett. 1991 Feb 11;66(6):838. No abstract available.

PMID:
10043914
45.

Pharmacokinetics and dynamics of furosemide in the newborn piglet.

Miceli JJ, Kramer PA, Chapron DJ, Rosenkrantz TS, Raye JR.

J Pharmacol Exp Ther. 1990 Jun;253(3):1126-32.

PMID:
2359020
46.

Renal response to furosemide in very low birth weight infants during chronic administration.

Mirochnick MH, Miceli JJ, Kramer PA, Chapron DJ, Raye JR.

Dev Pharmacol Ther. 1990;15(1):1-7.

PMID:
2242705
47.

High-performance liquid chromatographic assay for a novel psychotropic drug (CI-943) in cynomolgus monkey plasma.

Krcmarik CS, Miceli JJ, Pachla LA.

J Chromatogr. 1989 Nov 24;496(2):493-9. No abstract available.

PMID:
2613852
48.

Furosemide pharmacokinetics in very low birth weight infants.

Mirochnick MH, Miceli JJ, Kramer PA, Chapron DJ, Raye JR.

J Pediatr. 1988 Apr;112(4):653-7.

PMID:
3351693
49.

Measurement of the refractive-index profile in polycrystalline germanium-silicon alloy GRIN crystals.

Naughton DP, Miceli JJ Jr, Moore DT.

Appl Opt. 1988 Feb 1;27(3):505-7. doi: 10.1364/AO.27.000505.

PMID:
20523631
50.

Model for gradient formation in polycrystalline germanium-silicon alloy GRIN crystals via Czochralski crystal growing.

Miceli JJ Jr, Naughton DP.

Appl Opt. 1988 Feb 1;27(3):500-4. doi: 10.1364/AO.27.000500.

PMID:
20523630

Supplemental Content

Loading ...
Support Center